BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36559906)

  • 1. Modification of Commercial 3D Fused Deposition Modeling Printer for Extrusion Printing of Hydrogels.
    Koltsov SI; Statsenko TG; Morozova SM
    Polymers (Basel); 2022 Dec; 14(24):. PubMed ID: 36559906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheological Characterization and Printability of Polylactide (PLA)-Alumina (Al
    Smirnov A; Seleznev A; Peretyagin P; Bentseva E; Pristinskiy Y; Kuznetsova E; Grigoriev S
    Materials (Basel); 2022 Nov; 15(23):. PubMed ID: 36499897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
    Alhijjaj M; Belton P; Qi S
    Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D printing with a 3D printed digital material filament for programming functional gradients.
    Ahn SJ; Lee H; Cho KJ
    Nat Commun; 2024 May; 15(1):3605. PubMed ID: 38714684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Feasibility Study of Processing Polydimethylsiloxane⁻Sodium Carboxymethylcellulose Composites by a Low-Cost Fused Deposition Modeling 3D Printer.
    Calcagnile P; Cacciatore G; Demitri C; Montagna F; Esposito Corcione C
    Materials (Basel); 2018 Sep; 11(9):. PubMed ID: 30200428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Simple Mechanical Screening Method for Predicting the Feedability of a Pharmaceutical FDM 3D Printing Filament.
    Nasereddin JM; Wellner N; Alhijjaj M; Belton P; Qi S
    Pharm Res; 2018 May; 35(8):151. PubMed ID: 29855818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of FDM 3D Printed Medicines for Pediatrics: Considerations for Formulation Development, Filament Extrusion, Printing Process and Printer Design.
    Quodbach J; Bogdahn M; Breitkreutz J; Chamberlain R; Eggenreich K; Elia AG; Gottschalk N; Gunkel-Grabole G; Hoffmann L; Kapote D; Kipping T; Klinken S; Loose F; Marquetant T; Windolf H; Geißler S; Spitz T
    Ther Innov Regul Sci; 2022 Nov; 56(6):910-928. PubMed ID: 34826120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of filaments for fused deposition modeling 3D printing with medical grade poly(lactic-co-glycolic acid) copolymers.
    Feuerbach T; Callau-Mendoza S; Thommes M
    Pharm Dev Technol; 2019 Apr; 24(4):487-493. PubMed ID: 30149761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of fused deposition modeling 3D printers for pharmaceutical and medical applications.
    Feuerbach T; Kock S; Thommes M
    Pharm Dev Technol; 2018 Dec; 23(10):1136-1145. PubMed ID: 29938558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot Melt Extrusion and its Application in 3D Printing of Pharmaceuticals.
    Deshkar S; Rathi M; Zambad S; Gandhi K
    Curr Drug Deliv; 2021; 18(4):387-407. PubMed ID: 33176646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of Controlled Micrometric Fibers inside Printed Scaffolds Using Standard FDM 3D Printers.
    Del Barrio Cortés E; Matutano Molina C; Rodríguez-Lorenzo L; Cubo-Mateo N
    Polymers (Basel); 2022 Dec; 15(1):. PubMed ID: 36616446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple and fast method for screening production of polymer-ceramic filaments for bone implant printing using commercial fused deposition modelling 3D printers.
    Podgórski R; Wojasiński M; Trepkowska-Mejer E; Ciach T
    Biomater Adv; 2023 Mar; 146():213317. PubMed ID: 36738523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and implementation of a low cost bio-printer modification, allowing for switching between plastic and gel extrusion.
    Krige A; Haluška J; Rova U; Christakopoulos P
    HardwareX; 2021 Apr; 9():e00186. PubMed ID: 35492054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a quantitative method to evaluate the printability of filaments for fused deposition modeling 3D printing.
    Xu P; Li J; Meda A; Osei-Yeboah F; Peterson ML; Repka M; Zhan X
    Int J Pharm; 2020 Oct; 588():119760. PubMed ID: 32800939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fused Deposition Modeling 3D Printing in Oral and Maxillofacial Surgery: Problems and Solutions.
    Kamio T; Onda T
    Cureus; 2022 Sep; 14(9):e28906. PubMed ID: 36105906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual nozzle 3D printing system for super soft composite hydrogels.
    Dine A; Bentley E; PoulmarcK LA; Dini D; Forte AE; Tan Z
    HardwareX; 2021 Apr; 9():e00176. PubMed ID: 35492040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Pharmaceutical Applications of Hot-Melt Extrusion Coupled with Fused Deposition Modelling (FDM) 3D Printing for Personalised Drug Delivery.
    Tan DK; Maniruzzaman M; Nokhodchi A
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30356002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance.
    Bandari S; Nyavanandi D; Dumpa N; Repka MA
    Adv Drug Deliv Rev; 2021 May; 172():52-63. PubMed ID: 33571550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fused deposition modelling approach using 3D printing and recycled industrial materials for a sustainable environment: a review.
    Madhu NR; Erfani H; Jadoun S; Amir M; Thiagarajan Y; Chauhan NPS
    Int J Adv Manuf Technol; 2022; 122(5-6):2125-2138. PubMed ID: 36091410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
    Oladeji S; Mohylyuk V; Jones DS; Andrews GP
    Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.